Drawing for CANSINOBIO

USPTO serial 79200875

CANSINOBIO

Reviewed by CopyMark Law Group

Reg. 5283242Status 709
Filing date
Status date
Registration date
Sep 12, 2017
Examiner
BULLOFF, TOBY ELLEN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CANSINOBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, antivirals, antibodies for treatment in disease, tumor suppressing agents, for the treatment of infectious diseases and inflammation, and for the detection and treatment of cancer; Chemico-pharmaceutical preparations, namely, antivirals, tumor suppressing agents, for the treatment of infectious diseases and inflammation, and for the detection and treatment of cancer; Vaccines; Drugs for medical purposes, namely, antivirals, antibodies for treatment in disease, tumor suppressing agents, for the treatment of infectious diseases and inflammation, and for the detection and treatment of cancer; Media for bacteriological cultures; Chemical preparations for medical purposes, namely, antivirals, tumor suppressing agents, for the treatment of infectious diseases and inflammation, and for the detection and treatment of cancer; Cultures of microorganisms for medical and veterinary useSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 24, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB
Jan 3, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jan 2, 2025INPCINVALIDATION PROCESSED
Nov 30, 2024INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 29, 2024C71TCANCELLED SECTION 71
Jan 27, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Dec 20, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB
Dec 20, 2017FIMPFINAL DISPOSITION PROCESSED
Dec 12, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 12, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 27, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 7, 2017NPUBNOTICE OF PUBLICATION
May 19, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 18, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 24, 2017RFNTREFUSAL PROCESSED BY IB
Feb 11, 2017MAFRAPPLICATION FILING RECEIPT MAILED
Feb 8, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 8, 2017RFRRREFUSAL PROCESSED BY MPU
Feb 8, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 7, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 7, 2017DOCKASSIGNED TO EXAMINER
Feb 7, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 2, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance